Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions.
D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000188:drug therapy*; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage / Q000009:adverse effects*; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy; D007223:Infant; D007275:Injections, Intravenous; D008875:Middle Aged; D013451:Sulfonic Acids; D013997:Time Factors; D005719:gamma-Globulins / Q000627:therapeutic use
D007136:Immunoglobulins; D013451:Sulfonic Acids; D005719:gamma-Globulins